For past several years, DARPA has been pioneering a powerful new type of countermeasure against infectious disease called gene-encoded antibodies. They work by providing cells with genetic instructions for producing one or more highly protective antibodies against a given threat. Following direct delivery to a person, these countermeasures work quickly; cells begin producing and secreting antibodies within hours, providing near instantaneous protection against threat exposure.